Skip to content

A study of multidimensional long-term prognostic assessment and intervention strategies for respiratory infections in the elderly

A study of multidimensional long-term prognostic assessment and intervention strategies for respiratory infections in the elderly

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085045
Enrollment
Unknown
Registered
2024-05-30
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory infection

Interventions

Intervention group:Individualised rehabilitation programmes based on comprehensive assessment
control group:Routine anti-infective treatment programme

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: Screening criteria: 1. Aged =65 years; 2. Patients hospitalised for acute lower respiratory tract infections, which include acute tracheo-bronchitis, community-acquired pneumonia, acute exacerbation of chronic bronchitis or chronic obstructive pulmonary disease, bronchiectasis co-infections, and interstitial fibrosis co-infections; 3. Hospitalisation in this institution. Inclusion criteria: patients whom at least one dimension of the EQ-5D-5L was present and impaired (assessed at level >1) at the time of discharge from the hospital after meeting the above screening and exclusion criteria.

Exclusion criteria

Exclusion criteria: 1. Aged >100 years; 2. Unable to co-operate in completing the questionnaire and follow-up for various reasons (severe cognitive impairment, deafness, non-Chinese speaking, etc.); 3. Chronic infections including tuberculosis, fungal infections of the lungs, bacterial lung abscess, etc; 4. Acute heart attack (within 1 month), unstable angina pectoris, uncontrolled arrhythmia, active stage of infective endocarditis or pericarditis, severe aortic stenosis, uncontrolled heart failure, uncontrolled hypertension (resting systolic blood pressure >180mmHg, diastolic blood pressure >100mmHg), suspected aneurysm entrapment; 5. Acute pulmonary embolism or pulmonary infarction, lower extremity deep vein thrombosis; uncontrolled asthma, respiratory failure; history of spontaneous pneumothorax in the last 1 year or uncontrolled pneumothorax; 6. Previous psychiatric abnormality or under psychiatric treatment; previous personality disorder, mental retardation, brain injury, or brain disease 7. Persons with comorbid neuromuscular and other systemic disorders or other severe movement disorders such as joint deformities, diseases, or severe spinal joint pains that interfere with physical mobility 8. Who have participated in other rehabilitation studies within the past 6 months 9. Current participation in other interventional clinical trials (participation in observational clinical trials may be included); 10. Comorbid serious underlying disease with a life expectancy of survival of <1 year; 11. Prolonged bed rest; 12. Death during hospitalisation.

Design outcomes

Primary

MeasureTime frame
quality of life;emotional disorder;

Secondary

MeasureTime frame
death;re-hospitalization;Ability to perform daily activities;cognitive ability;nutrition;fall;immune;time to assessment;

Countries

China

Contacts

Public ContactYanming Li

Beijing Hospital

lymyl@263.net+86 136 0254 4317

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026